Racquet Club of Philadelphia
215 S. 16th Street
Philadelphia, PA 19102

Date: Monday, September 9th, 11:30 am to 1:00 pm

Program Presenter: Scott D. Milligan, Chief Executive Officer



Scott D. Milligan, Chief Executive Officer

  • 25 years of healthcare leadership, development and consulting experience
  • Led development of the largest privately owned radiosurgery network in the U.S.
  • VP of technology – led development and operation of the stereotactic radiosurgery business unit
  • Ernst & Young senior manager, Healthcare Provider Business Transformation Group
  • Pet parent to Huck, an English Golden Retriever


Our Mission

At PetCure Oncology, we provide pet families with support, knowledge and access to comprehensive and compassionate cancer care. We share the cancer journey with our patients and their families and believe they deserve the very best in clinical expertise and progressive treatment options.


Our Values

The following core values exemplify what PetCure Oncology is all about. Every PetCure location and every PetCure employee is committed to being:

  • Accountable
  • Authentic
  • Empathetic
  • Ethical
  • Innovative
  • Relentless


Our History

PetCure Oncology was created in 2014 by the founders of Accelitech®, the largest privately-held network of stereotactic radiosurgery (SRS) centers in the human cancer market, in response to a growing need for this technology in veterinary cancer care.

While SRS is widely available for treating human cancers—with the intent to cure—the veterinary field has a limited supply of advanced technology and services for treating the growing number of pets with cancer. Radiation equipment is outdated, start-up costs are prohibitive, and there is a significant shortage of board-certified veterinary radiation oncologists in the U.S.

As a result, pet owners have had few options. What’s more, traditional radiation therapy can require dozens of daily visits (and anesthetic events) over a six-week period, and can cause significant side effects for pets. It can also present a serious logistical challenge for pet owners.

As SRS begins to emerge in veterinary cancer care, early reports indicate good outcomes and fewer side effects than traditional radiation therapy, and pet owners appreciate the significant reduction in daily visits to three or fewer.

But preexisting centers can treat only a small percentage of the pets diagnosed with cancer each year. To fill this growing need, the Accelitech® founders are leveraging their extensive human radiosurgery expertise to roll out a national network of veterinary SRS centers in partnership with leading veterinary specialists and specialty animal hospitals across the U.S.

PSA Merchandise

Show off your PSA pride with our custom PSA merchandise!

Contact us with the names/quantities of the item(s). You may pick up your gift at our next event!